Therefore, we assessed the time dependent consequences of elevated HIF signaling on tumor progression and LPC activation by using the PAN-PHD inhibitor dimethyloxaloylglycine (DMOG) in an orthotopic HCC mouse model. This evidence concerns the gene PDC and hepatocellular carcinoma.